Home     Site Map     Legal   

  Overview

MBC Pharma, Inc. is a pharmaceutical company discovering and developing novel medicines for the treatment of oncology, bone and infectious diseases. MBC Pharma's patented technologies improve upon the benefit of known drugs by adding tissue targeting and increased cancer cell specificity and uptake.

MBC Pharma's mission is to create value through discovery and development novel therapeutics to treat important oncological, bone and infectious diseases, using the Company's platform technologies.

MBC R&D programs are based on two core proprietary discovery platforms

  • Bone-targeting using bone-homing bisphosphonates conjugated to either anticancer or anti-infective drug payloads.
    • First-in-Class: Human proof of concept demonstrated by MBC-11 in a Phase I clinical trial in patients with established bone lesions due to breast, prostate or cervical cancer.
    • Novel platform expanding compounds are under pre-clinical development.

  • Vitamin B6-based nucleotide pro-drugs - oncology and viral diseases indications

MBC Pharma, Inc.   12635 E.Montview Blvd., Suite 100  Aurora, CO 80045
Phone: 720-859-4041  Fax: 303-484-3532
Email: information@mbcpharma.com